Clinilabs Drug Development Corporation provides access to the world’s largest population of racially diverse clinical trial participants. We recruit healthy volunteers, patients, and specialty groups from a population of more than 19 million people in the New York metropolitan area. Our on-site call center employs highly-experienced, multilingual associates who pre-screen study candidates using the latest technology in order to ensure that our proprietary database is the most robust in the industry. We currently have more than 24,000 study candidates in our database. Click here to determine if our database includes the subject population that you are seeking.
Clinilabs Drug Development Corporation promotes gender and racial diversity in clinical trials.
Normal Healthy Subjects
Treatment resistant depression
Substance use disorders
Mild cognitive impairment
Epilepsy (generalized and partial seizures)
Circadian rhythm disorders
Endocrine and Metabolic Disorders
Men’s and Women’s Health
I am not accustomed to saying anything with certainty after only one or two observations.
– Andreas Vesalius